Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study

Name: Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study
License: Public Domain

Shanghai Cancer Hospital, China

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

lung neoplasms

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 332757
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.